Penserra Capital Management LLC Amgen Inc Transaction History

Penserra Capital Management LLC

$7.96 Billion
Q1 2024

A detailed history of Penserra Capital Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Penserra Capital Management LLC holds 275,441 shares of AMGN stock, worth $86.1 Million. This represents 0.98% of its overall portfolio holdings.

Number of Shares

275,441

Previous 2,478 11015.46%

Holding current value

$86.1 Million

Previous $712,000 10898.88%

% of portfolio

0.98%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $73.4 Million - $88.6 Million	272,963 Added 11015.46%	275,441 $78.3 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $132,452 - $149,422	-518 Reduced 17.29%	2,478 $712,000
Q3 2023 Nov 15, 2023	SELL	$218.65 - $271.46 $101,890 - $126,500	-466 Reduced 13.46%	2,996 $805,000
Q2 2023 Aug 11, 2023	BUY	$214.27 - $253.37 $735,803 - $870,072	3,434 Added 12264.29%	3,462 $767,000
Q1 2023 Apr 24, 2023	SELL	$225.79 - $275.2 $67.4 Million - $82.1 Million	-298,458 Reduced 99.99%	28 $6,000

Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $68.4 Million - $86.9 Million	298,486 New	298,486 $78.4 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $24,916 - $27,727	-108 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $14,471 - $16,009	-66 Reduced 37.93%	108 $26,000
Q4 2021 Feb 15, 2022	BUY	$198.88 - $227.6 $2,386 - $2,731	12 Added 7.41%	174 $39,000
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $7,853 - $9,201	37 Added 29.6%	162 $34,000
Q2 2021 Aug 12, 2021	SELL	$233.58 - $259.14 $9.84 Million - $10.9 Million	-42,119 Reduced 99.7%	125 $30,000
Q1 2021 May 13, 2021	BUY	$221.91 - $258.6 $3.83 Million - $4.46 Million	17,253 Added 69.04%	42,244 $10.5 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $2.84 Million - $3.38 Million	13,112 Added 110.38%	24,991 $5.75 Million
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $2.7 Million - $3 Million	11,502 Added 3050.93%	11,879 $3.02 Million
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $74,574 - $91,512	377 New	377 $88,000
Q4 2018 Feb 06, 2019	SELL	$178.4 - $208.25 $361,081 - $421,498	-2,024 Closed	0 $0
Q3 2018 Nov 05, 2018	BUY	$185.29 - $208.89 $27,793 - $31,333	150 Added 8.0%	2,024 $419,000
Q2 2018 Aug 13, 2018	BUY	$166.05 - $186.51 $58,781 - $66,024	354 Added 23.29%	1,874 $345,000
Q1 2018 May 08, 2018	BUY	$169.43 - $198.0 $20,331 - $23,760	120 Added 8.57%	1,520 $259,000
Q4 2017 Feb 07, 2018	BUY	$168.79 - $188.59 $37,133 - $41,489	220 Added 18.64%	1,400 $243,000
Q3 2017 Oct 26, 2017	BUY	$167.29 - $191.0 $23,420 - $26,740	140 Added 13.46%	1,180 $220,000
Q2 2017 Aug 21, 2017	BUY	N/A	1,040	1,040 $179,000

Others Institutions Holding AMGN

# of Institutions

2,930

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $167B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.

Account

Penserra Capital Management LLC Amgen Inc Transaction History